From: Proteinuria and baseline renal function predict mortality and renal outcomes after sirolimus therapy in liver transplantation recipients
Variable
N (%)
Renal dysfunctiona
318 (55.2)
HCC
 Prophylaxis
93 (16.1)
 Recurrence
21 (3.6)
Non-hepatic tumors
18 (3.1)
Biopsy proved acute/chronic rejection
84 (14.6)
Neurotoxicity
5 (0.9)
Other side effects from immunosuppressants
37 (6.4)